Ionis Pharmaceuticals (NASDAQ: IONS) beat management's expectations in the fourth quarter, as it closed out its third consecutive year of adjusted operating profitability helping the company fund the development of its pipeline.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,